The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Ecofibre’s (EOF) subsidiary, EOF Distribution, has entered an exclusive distribution agreement with CVS Pharmacy
  • The company will distribute topical hemp-derived products for sale across CVS locations
  • These include roll-ons, lotions and healing ointments — all of which contain active cannabinoids
  • The products are expected to be available for purchase in December this year
  • Ecofibre is up 7.83 per cent and shares are trading for $3.03 each

Ecofibre’s (EOF) subsidiary, EOF Distribution, has entered an exclusive distribution agreement with CVS Pharmacy.

Under the agreement, EOF Distribution will distribute topical hemp-derived products for sale across CVS locations.

Topical cream products under Ecofibre’s Ananda Hemp business include roll-on deodorants, lotions and healing ointments — all of which contain active cannabinoids.

The company will initially supply 10 products at select CVS Pharmacy locations. All of the products will be manufactured in Ecofibre’s new U.S. Headquarters, which are located in Georgetown, Kentucky.

“We are very pleased to have been selected to supply this brand of products to be offered exclusively at CVS, and are excited at the long-term prospects of providing high-quality hemp-derived products to a broad range of consumers,” EOFD CEO David Neu said.

The agreement is ongoing and covers potential future purchase orders with no specified minimum or maximum value.

The products are expected to be available for purchase at select CVS locations in December this year.

Ecofibre is up 7.83 per cent and shares are trading for $3.03 each at 12:58 pm AEST.

EOF by the numbers
More From The Market Online

What it takes to get a new drug to market in Australia

In this latest version of Thematica from TMO, we're taking a break from mines and battery…

4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study

Respiratory imaging technology company, 4DMedical (ASX:4DX) has entered into a research agreement with the West Los…

Recce Pharma picks up Chinese patent for anti-infective drugs

Recce Pharmaceuticals (ASX:RCE) has confirmed its receipt of a patent in China to protect its class…

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…